Jan Voss

AI is a viable alternative to high throughput screening: a 318-target study

Izhar Wallach, Denzil Bernard, Kong T. Nguyen et al. · Scientific Reports · 2024 · 120 citations · Full text

Pharmacy, Bioinformatics, Medicinal Chemistry +16

The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways

Jan Voss, Guido Posern, Jürgen Hannemann et al. · Oncogene · 2000 · 78 citations

Medicine, Cancer Biology, Molecular Biology +8

Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G

Guido Posern, Jie Zheng, Beatrice S Knudsen et al. · Oncogene · 1998 · 78 citations

Life Sciences, Biochemistry, Molecular Biology +12

Macrocyclic Gq Protein Inhibitors FR900359 and/or YM-254890–Fit for Translation?

Jonathan G. Schlegel, Mariam Tahoun, Alexander Seidinger et al. · ACS Pharmacology & Translational Science · 2021 · 34 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Tumor-Derived Mutated E-Cadherin Influences<i>β</i>-Catenin Localization and Increases Susceptibility to Actin Cytoskeletal Changes Induced by Pervanadate

Birgit Luber, Sonja Candidus, Gabriele Handschuh et al. · Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication · 2000 · 33 citations

Life Sciences, Cell Biology, Molecular Biology +17